Ciprofloxacin in the treatment of urinary tract infection in patients with multiple sclerosis
- 1 April 1986
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 5 (2) , 251-253
- https://doi.org/10.1007/bf02014002
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The in vitro and in vivo activity of ciprofloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Pseudomonas infections in Multiple SclerosisAntonie van Leeuwenhoek, 1984
- Neuro-muscular dysfunction of the lower urinary tract in multiple sclerosisSpinal Cord, 1983
- Activity of ciprofloxacin (BAYo 9867) against pseudomonas aeruginosa and ampicillin-resistant EnterobacteriaceaeInfection, 1983
- Pharmacokinetics and tissue penetration of ciprofloxacinAntimicrobial Agents and Chemotherapy, 1983
- In vitro activity of ciprofloxacin (Bay o 9867)Antimicrobial Agents and Chemotherapy, 1983
- Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acidAntimicrobial Agents and Chemotherapy, 1983
- In vitro activity of ciprofloxacin, norfloxacin and nalidixic acidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1983
- [Microbiological approach to urinary infections with Pseudomonas aeruginosa].1979